Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
Martinot-Peignoux M, Maylin S, Moucari R, Ripault MP, Boyer N, Cardoso AC, Giuily N, Castelnau C, Pouteau M, Stern C, Aupérin A, Bedossa P, Asselah T, Marcellin P.
Martinot-Peignoux M, et al. Among authors: pouteau m.
Antivir Ther. 2009;14(4):501-11.
Antivir Ther. 2009.
PMID: 19578235
Clinical Trial.